China
Generic medications and Asia-Pacific health systems: A viable win-win-win strategy?
Generic medications and Asia-Pacific health systems: A viable win-win-win strategy?
This article explains in greater detail the challenges faced by the generic drug manufacturing industry.
Ping An Good Doctor's revenue rose 35.5% to $1.06b in 2020
The company’s average daily consultations jumped 23.9% to 903,000.
111 rolls out mobile healthcare services in Northeast China
Baiyi Doctor Group will provide internet-based diagnosis and treatment.
Rising population boosts APAC's over-the-counter drugs market
In countries with high populations, patients rely on neighborhood chemists for medications.
China's online healthcare untouched by internet antitrust push
Shares of online healthcare firms soared despite new antitrust laws on internet companies.
APAC's sterilization equipment market on the rise as hospitals multiply
The region accounts for more than 20% of the market globally.
Aoyuan Healthy acquires 55% equity in Liantianmei for $101.72m
With this acquisition, Aoyuan holds 60% equity interest in the company.
Chinese pharma market to grow 3.2% this year
The Government’s efforts to cut drug spending will create challenges for international drugmakers.
HSBC releases China pharma market outlook for H2
Small cap companies with low valuations could outperform, but leading companies may provide more stable returns.
Sino Biopharma records $1,852m revenue in H1
Earnings per share were 5.2% higher than that of the same period last year.
Lee's Pharma announces H1 results
The group’s revenue is up 3.9% measured QoQ.
Viva Biotech buys 80% share of Langhua Pharma
The company expects to deliver more comprehensive end-to-end services through this acquisition.
China's healthcare spending to reach $49b by 2023
By then, China will account for 23% of the world’s healthcare spending.
Telemedicine is seeing a radical surge in China
Study revealed around 90% are using online medical services with no intention of reverting to offline sources.
Almost 70% of rare disease patients receiving poor medical attention
Funding for testing and treatment, among others, was cited as the reason behind the inefficiencies across Asia-Pacific.
Bigger healthcare spending in the cards for China
The country saw overwhelmed hospitals and disrupted routine services amidst the pandemic.
KPMG's Chris Hardesty gives a diagnosis of healthcare's present and future
He says health literacy has increased dramatically as a result of the global health situation.
Most Read
1. Ciputra Mitra Hospital speeds up heart and stroke response 2. New Zealand’s Whangārei Hospital parking expansion underway 3. Digital pathology market to be valued at $1.91b by 2032 4. APAC emerges as key player in global neurology devices market 5. NUHS secures $1.81m for AI-powered dementia prevention researchResource Center
Read Here
Advertise
Sign Up
Event News
Healthcare Asia Awards 2025 Winner: Tanupol Virunhagarun, M.D. of BDMS Wellness Clinic
Tanupol Virunhagarun, M.
